After years of delay, the FDA has finally approved generic EpiPen
A few years ago, the company that made the EpiPen, Mylan, hiked the price of its life-saving device a stunning four-hundred percent. Many blamed the hike, in part, on the FDA’s delay in approving the generic version of the EpiPen. Finally, a company called Teva has been approved to produce a competing, generic EpiPen. The FDA commissioner stated: “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages,”
Full story at CNBC.
More news.Posted by Josh Urich